Back To Rising Leaders Gallery
With cell and gene therapy being one of the hottest areas of biotech, it can be hard to stand out....
Elicera To Advance Next-Gen Cell Therapies Following IPO
Interview With CEO Jamal El-Mosleh
Sweden-based Elicera Therapeutics is developing next-generation oncolytic viruses and “fourth-generation” CAR-T cells. CEO Jamal El-Mosleh sat down with In Vivo ahead of the company’s IPO.
